Contents

Editorials
221 The chemotherapy of leprosy: An interpretive history R.H. GELBER AND J. GROSSET

241 Developing new MDT regimens for MB patients; Time to test ROM 12 month regimens globally D.N.J. LOCKWOOD AND M.D.G. CUNHA

Commentary
245 Chemotherapy of leprosy has changed (almost) everything D.M. SCOLLARD

Original Papers
247 Relapses in multibacillary leprosy patients: A retrospective cohort of 11 years in Colombia M.I. GUERRERO-GUERRERO, S. MUVDI-ARENAS AND C.I. LEÓN-FRANCO

261 OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil M.D.G.S. CUNHA, M. VIRMOND, A.P. SCHETTINI, R.C. CRUZ, S. URA, C. GHUIDELLA, F.D.R. VIANA, J.C.R. AVELLEIRA AND A.A.A.C.B. FILHO

269 Drug-resistant leprosy: Monitoring and current status D.L. WILLIAMS AND T.P. GILLIS

282 Assessing and improving adherence with multidrug therapy D. WEIAND, J. THOULASS AND W.C.S. SMITH

292 Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh S.G. FEENSTRA, D. PAHAN, F.J. MOET, L. OSKAM AND J.H. RICHARDUS

305 Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy P. DEPS, P. GUERRA, S. NASSER AND M. SIMON

308 Primary results of Clinical Trial for Uniform Multidrug Therapy for Leprosy Patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients M.L.F. PENNA, S. BU˝HRER-SÉKULA, M.A.D.A. PONTES, R. CRUZ, H.D.S. GONÇALVES AND G.O. PENNA

320 Book Review DR. B. KUMAR

322 Obituary L. HOGERZEIL